# Prevalence and Causes of Stigmatization Among Patients With Chronic Skin Diseases in Saudi Arabia

**Authors:** Yassmeen Hmoud Alblowi, Ahmed A Alsaati, Amirah Saleh Alzubaidi, Sahar Saud Alsifri, Yousef AlHarthi, Moteb Khalaf Alotaibi

PMC · DOI: 10.7759/cureus.59373 · Cureus · 2024-04-30

## TL;DR

This study found that 90% of Saudi patients with chronic skin diseases face stigmatization, with factors like gender and facial lesions increasing stigma.

## Contribution

The study identifies specific risk factors for stigmatization in chronic skin disease patients in Saudi Arabia.

## Key findings

- 90.4% of patients with chronic skin diseases experienced stigmatization.
- Male gender and facial lesions were significant predictors of higher stigmatization.
- Patients with a family history of skin conditions also faced increased stigma.

## Abstract

Background: Skin diseases can lead to stigmatization with negative consequences for patients' quality of life and mental health.

Aim: The aim of this study was to estimate the prevalence of stigmatization experienced by patients with vitiligo, psoriasis, acne, rosacea, or atopic dermatitis and to assess the relationships between the level of stigmatization and patient characteristics.

Methods: This cross-sectional study included adult patients with vitiligo, psoriasis, acne, rosacea, or atopic dermatitis attending the dermatology clinics of various general hospitals in Saudi Arabia. Stigma levels were assessed using the six-item Stigma Scale.

Results: The prevalence of stigmatization was 90.4% among the 280 patients included. Multiple regression analyses revealed the factors that independently and significantly increased the level of stigmatization. These included male gender (B = 4.300, 95%CI 3.407-5.192, P <0.001), positive family history of skin conditions (B = 2.267, 95%CI 1.139-3.395, P <0.001), number of skin diseases (B = 2.357, 95%CI 0.998-3.716, P = 0.001), and presence of facial lesions (B = 2.455, 95%CI 1.206-3.705, P<0.001).

Conclusions: The prevalence of stigmatization is high among patients with chronic skin diseases in Saudi Arabia. Identifying patients at risk for high levels of stigmatization may allow them to be provided with appropriate social and psychological support.

## Linked entities

- **Diseases:** vitiligo (MONDO:0008661), psoriasis (MONDO:0005083), acne (MONDO:0011438), rosacea (MONDO:0006604), atopic dermatitis (MONDO:0004980)

## Full-text entities

- **Diseases:** facial lesions (MESH:D005155), vitiligo (MESH:D014820), Chronic Skin Diseases (MESH:D012871), acne (MESH:D000152), rosacea (MESH:D012393), psoriasis (MESH:D011565), atopic dermatitis (MESH:D003876)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11139009/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11139009/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC11139009/full.md

---
Source: https://tomesphere.com/paper/PMC11139009